Last reviewed · How we verify

Probiotic plus lactulose — Competitive Intelligence Brief

Probiotic plus lactulose (Probiotic plus lactulose) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Probiotic + prebiotic combination. Area: Gastroenterology.

marketed Probiotic + prebiotic combination Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Probiotic plus lactulose (Probiotic plus lactulose) — Qurratul Ain Jamil. Probiotics restore beneficial gut bacteria while lactulose acts as a prebiotic osmotic laxative to promote bowel regularity and support gastrointestinal health.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Probiotic plus lactulose TARGET Probiotic plus lactulose Qurratul Ain Jamil marketed Probiotic + prebiotic combination

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Probiotic + prebiotic combination class)

  1. Qurratul Ain Jamil · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Probiotic plus lactulose — Competitive Intelligence Brief. https://druglandscape.com/ci/probiotic-plus-lactulose. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: